These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8921436)

  • 1. Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism.
    Hoerauf A; Röllinghoff M; Solbach W
    Int Immunol; 1996 Oct; 8(10):1569-75. PubMed ID: 8921436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.
    Varkila K; Chatelain R; Leal LM; Coffman RL
    Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
    Gessner A; Blum H; Röllinghoff M
    Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice.
    Ronet C; Voigt H; Himmelrich H; Doucey MA; Hauyon-La Torre Y; Revaz-Breton M; Tacchini-Cottier F; Bron C; Louis J; Launois P
    J Immunol; 2008 Apr; 180(7):4825-35. PubMed ID: 18354206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell and non-T cell compartments can independently determine resistance to Leishmania major.
    Shankar AH; Titus RG
    J Exp Med; 1995 Mar; 181(3):845-55. PubMed ID: 7869047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
    Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
    J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of antigen-presenting cell type and interferon-gamma on priming and cytokine secretion of Leishmania major-specific T cells.
    Shankar AH; Titus RG
    J Infect Dis; 1997 Jan; 175(1):151-7. PubMed ID: 8985210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
    Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
    Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of IL-7 treatment on Leishmania major-infected BALB.Xid mice: enhanced lymphopoiesis with sustained lack of B1 cells and clinical aggravation of disease.
    Hoerauf A; Solbach W; Röllinghoff M; Gessner A
    Int Immunol; 1995 Nov; 7(11):1879-84. PubMed ID: 8580086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis.
    Satoskar A; Brombacher F; Dai WJ; McInnes I; Liew FY; Alexander J; Walker W
    J Immunol; 1997 Nov; 159(10):5005-13. PubMed ID: 9366428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
    Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.
    Holowka T; Castilho TM; Garcia AB; Sun T; McMahon-Pratt D; Bucala R
    FASEB J; 2016 Jun; 30(6):2249-65. PubMed ID: 26956417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
    Mitchell GF
    J Immunogenet; 1983 Oct; 10(5):395-412. PubMed ID: 6606002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.
    Woelbing F; Kostka SL; Moelle K; Belkaid Y; Sunderkoetter C; Verbeek S; Waisman A; Nigg AP; Knop J; Udey MC; von Stebut E
    J Exp Med; 2006 Jan; 203(1):177-88. PubMed ID: 16418399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of scid mice to establishment of Leishmania major infection.
    Guy RA; Belosevic M
    Clin Exp Immunol; 1995 Jun; 100(3):440-5. PubMed ID: 7774053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.